Terms: = Lung cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
14440 results:
1. Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice.
Ling C; Liu SS; Wang YY; Huo GT; Yang YW; Xu N; Wang H; Wu Y; Miao YF; Fu R; Zhao YW; Fan CF
Zool Res; 2024 May; 45(3):551-566. PubMed ID: 38757223
[TBL] [Abstract] [Full Text] [Related]
2. Development of a novel laboratory photodynamic therapy device: automated multi-mode LED system for optimum well-plate irradiation.
Yildiz MZ; Kamanli AF; Eskiler GG; Tabakoğlu HÖ; Pala MA; Özdemir AE
Lasers Med Sci; 2024 May; 39(1):131. PubMed ID: 38750381
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell transcriptome analysis reveals heterogeneity of neutrophils in non-small cell lung cancer.
Wang Y; Zhu Z; Luo R; Chen W
J Gene Med; 2024 May; 26(5):e3690. PubMed ID: 38735760
[TBL] [Abstract] [Full Text] [Related]
4. Acute cardiac tamponade after Endostar treatment of non-small cell lung cancer: A case report.
Dong W; Wang M; Zhu P; Sun Q; Wu D
Medicine (Baltimore); 2024 May; 103(19):e38106. PubMed ID: 38728498
[TBL] [Abstract] [Full Text] [Related]
5. Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.
Beauchamp E; Gamma JM; Cromwell CR; Moussa EW; Pain R; Kostiuk MA; Acevedo-Morantes C; Iyer A; Yap M; Vincent KM; Postovit LM; Julien O; Hubbard BP; Mackey JR; Berthiaume LG
J Transl Med; 2024 May; 22(1):431. PubMed ID: 38715059
[TBL] [Abstract] [Full Text] [Related]
6. Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging.
Mierzwicka JM; Petroková H; Kafková LR; Kosztyu P; Černý J; Kuchař M; Petřík M; Bendová K; Krasulová K; Groza Y; Vaňková L; Bharadwaj S; Panova N; Křupka M; Škarda J; Raška M; Malý P
J Transl Med; 2024 May; 22(1):426. PubMed ID: 38711085
[TBL] [Abstract] [Full Text] [Related]
7. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant lung cancer.
Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
[TBL] [Abstract] [Full Text] [Related]
8. Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4.
Santiso A; Heinemann A; Kargl J
Pharmacol Rev; 2024 May; 76(3):388-413. PubMed ID: 38697857
[TBL] [Abstract] [Full Text] [Related]
9. Design, synthesis, and antitumor activity evaluation of potent fourth-generation EGFR inhibitors for treatment of Osimertinib resistant non-small cell lung cancer (NSCLC).
Zhang Y; Tong L; Yan F; Huang P; Zhu CL; Pan C
Bioorg Chem; 2024 Jun; 147():107394. PubMed ID: 38691906
[TBL] [Abstract] [Full Text] [Related]
10. The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability.
Abad E; Sandoz J; Romero G; Zadra I; Urgel-Solas J; Borredat P; Kourtis S; Ortet L; Martínez CM; Weghorn D; Sdelci S; Janic A
J Exp Clin Cancer Res; 2024 Apr; 43(1):127. PubMed ID: 38685100
[TBL] [Abstract] [Full Text] [Related]
11. [Staging and systemic treatment of ocular and periocular metastases].
Dörfel D; Babst N; Heindl LM; Kakkassery V; Müller MR
Ophthalmologie; 2024 May; 121(5):374-381. PubMed ID: 38683363
[TBL] [Abstract] [Full Text] [Related]
12. [Interpretation of global lung cancer statistics].
Cai L; Zhu CX; Zhang XL; Fang Y; Yang HY; Guo LW
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Apr; 45(4):585-590. PubMed ID: 38678357
[TBL] [Abstract] [Full Text] [Related]
13. A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy.
Ascheid D; Baumann M; Pinnecker J; Friedrich M; Szi-Marton D; Medved C; Bundalo M; Ortmann V; Öztürk A; Nandigama R; Hemmen K; Ergün S; Zernecke A; Hirth M; Heinze KG; Henke E
Nat Commun; 2024 Apr; 15(1):3599. PubMed ID: 38678014
[TBL] [Abstract] [Full Text] [Related]
14. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions.
Yin H; Wang Z; Lv X; Wang Z; Wang Y; Fan W; Li S; Jiang L; Cao J; Liu Y
Chem Biol Interact; 2024 May; 395():111023. PubMed ID: 38677539
[TBL] [Abstract] [Full Text] [Related]
16. Effects of Reduced Extracellular Sodium Concentrations on Cisplatin treatment in Human Tumor Cells: The Role of Autophagy.
Naldi L; Fibbi B; Anceschi C; Nardini P; Guasti D; Peri A; Marroncini G
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673964
[TBL] [Abstract] [Full Text] [Related]
17. Modulation of epithelial-mesenchymal transition by gemcitabine: Targeting ionizing radiation-induced cellular senescence in lung cancer cell.
Zhou H; Li C; Ren Y; Wang WA; Zhuang J; Ren Y; Shen L; Chen Y
Biochem Pharmacol; 2024 Jun; 224():116234. PubMed ID: 38670436
[TBL] [Abstract] [Full Text] [Related]
18. Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis.
Wang J; Guo Z; Shen M; Xie Q; Xiang H
Front Immunol; 2024; 15():1366489. PubMed ID: 38660314
[TBL] [Abstract] [Full Text] [Related]
19. Keratin 6A (KRT6A) promotes radioresistance, invasion, and metastasis in lung cancer via p53 signaling pathway.
Xu Q; Yu Z; Mei Q; Shi K; Shen J; Gao G; Liu S; Li M
Aging (Albany NY); 2024 Apr; 16(8):7060-7072. PubMed ID: 38656878
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy of Sorafenib-Based Therapies for Non-Small Cell lung cancer.
Hendrixson M; Gladkiy Y; Thyagarajan A; Sahu RP
Med Sci (Basel); 2024 Apr; 12(2):. PubMed ID: 38651414
[TBL] [Abstract] [Full Text] [Related]
[Next]
